| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:50 UTC |
|---|
| Update Date | 2022-03-07 02:51:48 UTC |
|---|
| HMDB ID | HMDB0014979 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Dobutamine |
|---|
| Description | Dobutamine is only found in individuals that have used or taken this drug. It is a beta-2 agonist catecholamine that has cardiac stimulant action without evoking vasoconstriction or tachycardia. It is proposed as a cardiotonic after myocardial infarction or open heart surgery. [PubChem]Dobutamine directly stimulates beta-1 receptors of the heart to increase myocardial contractility and stroke volume, resulting in increased cardiac output. |
|---|
| Structure | CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1 InChI=1S/C18H23NO3/c1-13(2-3-14-4-7-16(20)8-5-14)19-11-10-15-6-9-17(21)18(22)12-15/h4-9,12-13,19-22H,2-3,10-11H2,1H3 |
|---|
| Synonyms | | Value | Source |
|---|
| (+-)-4-(2-((3-(p-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol | ChEBI | | 3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenylethylamine | ChEBI | | 4-{2-[3-(4-hydroxy-phenyl)-1-methyl-propylamino]-ethyl}-benzene-1,2-diol | ChEBI | | DL-Dobutamine | ChEBI | | Dobutamina | ChEBI | | Dobutaminum | ChEBI | | rac-Dobutamine | ChEBI | | Racemic-dobutamine | ChEBI | | 3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-b-phenylethylamine | Generator | | 3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-β-phenylethylamine | Generator | | Dobucor | HMDB | | Dobuject | HMDB | | Dobutamin hexal | HMDB | | Dobutamin ratiopharm | HMDB | | Dobutamin-ratiopharm | HMDB | | Fresenius brand OF dobutamine hydrochloride | HMDB | | Hydrochloride, dobutamine | HMDB | | Inibsa brand OF dobutamine hydrochloride | HMDB | | Rovi brand OF dobutamine hydrochloride | HMDB | | Dobutamin fresenius | HMDB | | Dobutamine hydrochloride | HMDB | | Dobutamine tartrate | HMDB | | Dobutamine tartrate (1:1), (R-(r*,r*))-isomer | HMDB | | Dobutamine tartrate (1:1), (S-(r*,r*))-isomer | HMDB | | Dobutamine, (-)-isomer | HMDB | | Juste brand OF dobutamine hydrochloride | HMDB | | Lactobionate, dobutamine | HMDB | | Pisa brand OF dobutamine hydrochloride | HMDB | | Dobutamin solvay | HMDB | | Dobutamine phosphate (1:1) salt, (-)-isomer | HMDB | | Dobutamine, phosphate (1:1) salt (+)-isomer | HMDB | | Eli lilly brand OF dobutamine hydrochloride | HMDB | | Irisfarma brand OF dobutamine hydrochloride | HMDB | | Kendrick brand OF dobutamine hydrochloride | HMDB | | Lilly brand OF dobutamine hydrochloride | HMDB | | Solvay brand OF dobutamine hydrochloride | HMDB | | Boehringer ingelheim brand OF dobutamine hydrochloride | HMDB | | Dobutamina inibsa | HMDB | | Dobutamina rovi | HMDB | | Dobutamine (+)-isomer | HMDB | | Dobutamine hydrobromide | HMDB | | Dobutamine lactobionate | HMDB | | Dobutrex | HMDB | | Hexal brand OF dobutamine hydrochloride | HMDB | | Hydrobromide, dobutamine | HMDB | | Lilly 81929 | HMDB | | Oxiken | HMDB | | Posiject | HMDB | | Tartrate, dobutamine | HMDB | | Ratiopharm brand OF dobutamine hydrochloride | HMDB |
|
|---|
| Chemical Formula | C18H23NO3 |
|---|
| Average Molecular Weight | 301.3801 |
|---|
| Monoisotopic Molecular Weight | 301.167793607 |
|---|
| IUPAC Name | 4-(2-{[4-(4-hydroxyphenyl)butan-2-yl]amino}ethyl)benzene-1,2-diol |
|---|
| Traditional Name | dobutamine |
|---|
| CAS Registry Number | 34368-04-2 |
|---|
| SMILES | CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1 |
|---|
| InChI Identifier | InChI=1S/C18H23NO3/c1-13(2-3-14-4-7-16(20)8-5-14)19-11-10-15-6-9-17(21)18(22)12-15/h4-9,12-13,19-22H,2-3,10-11H2,1H3 |
|---|
| InChI Key | JRWZLRBJNMZMFE-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as catecholamines and derivatives. Catecholamines and derivatives are compounds containing 4-(2-Aminoethyl)pyrocatechol [4-(2-aminoethyl)benzene-1,2-diol] or a derivative thereof formed by substitution. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Phenols |
|---|
| Sub Class | Benzenediols |
|---|
| Direct Parent | Catecholamines and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Catecholamine
- Phenethylamine
- 1-hydroxy-4-unsubstituted benzenoid
- 1-hydroxy-2-unsubstituted benzenoid
- Aralkylamine
- Monocyclic benzene moiety
- Secondary aliphatic amine
- Secondary amine
- Organopnictogen compound
- Organooxygen compound
- Organonitrogen compound
- Amine
- Organic oxygen compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.014 g/L | Not Available | | LogP | 3.6 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections| Adduct Type | Data Source | CCS Value (Å2) | Reference |
|---|
| [M+H]+ | CBM | 168.2 | 30932474 |
|
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 4.23 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.3813 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 4.0 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 84.5 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Dobutamine,1TMS,isomer #1 | CC(CCC1=CC=C(O[Si](C)(C)C)C=C1)NCCC1=CC=C(O)C(O)=C1 | 2898.0 | Semi standard non polar | 33892256 | | Dobutamine,1TMS,isomer #2 | CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O[Si](C)(C)C)=C1 | 2863.4 | Semi standard non polar | 33892256 | | Dobutamine,1TMS,isomer #3 | CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O[Si](C)(C)C)C(O)=C1 | 2894.4 | Semi standard non polar | 33892256 | | Dobutamine,1TMS,isomer #4 | CC(CCC1=CC=C(O)C=C1)N(CCC1=CC=C(O)C(O)=C1)[Si](C)(C)C | 3066.3 | Semi standard non polar | 33892256 | | Dobutamine,2TMS,isomer #1 | CC(CCC1=CC=C(O[Si](C)(C)C)C=C1)NCCC1=CC=C(O[Si](C)(C)C)C(O)=C1 | 2810.8 | Semi standard non polar | 33892256 | | Dobutamine,2TMS,isomer #2 | CC(CCC1=CC=C(O[Si](C)(C)C)C=C1)NCCC1=CC=C(O)C(O[Si](C)(C)C)=C1 | 2801.5 | Semi standard non polar | 33892256 | | Dobutamine,2TMS,isomer #3 | CC(CCC1=CC=C(O[Si](C)(C)C)C=C1)N(CCC1=CC=C(O)C(O)=C1)[Si](C)(C)C | 2991.7 | Semi standard non polar | 33892256 | | Dobutamine,2TMS,isomer #4 | CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=C1 | 2864.5 | Semi standard non polar | 33892256 | | Dobutamine,2TMS,isomer #5 | CC(CCC1=CC=C(O)C=C1)N(CCC1=CC=C(O)C(O[Si](C)(C)C)=C1)[Si](C)(C)C | 2961.8 | Semi standard non polar | 33892256 | | Dobutamine,2TMS,isomer #6 | CC(CCC1=CC=C(O)C=C1)N(CCC1=CC=C(O[Si](C)(C)C)C(O)=C1)[Si](C)(C)C | 2989.7 | Semi standard non polar | 33892256 | | Dobutamine,3TMS,isomer #1 | CC(CCC1=CC=C(O[Si](C)(C)C)C=C1)NCCC1=CC=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=C1 | 2884.6 | Semi standard non polar | 33892256 | | Dobutamine,3TMS,isomer #2 | CC(CCC1=CC=C(O[Si](C)(C)C)C=C1)N(CCC1=CC=C(O[Si](C)(C)C)C(O)=C1)[Si](C)(C)C | 2963.9 | Semi standard non polar | 33892256 | | Dobutamine,3TMS,isomer #3 | CC(CCC1=CC=C(O[Si](C)(C)C)C=C1)N(CCC1=CC=C(O)C(O[Si](C)(C)C)=C1)[Si](C)(C)C | 2943.9 | Semi standard non polar | 33892256 | | Dobutamine,3TMS,isomer #4 | CC(CCC1=CC=C(O)C=C1)N(CCC1=CC=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=C1)[Si](C)(C)C | 2968.2 | Semi standard non polar | 33892256 | | Dobutamine,4TMS,isomer #1 | CC(CCC1=CC=C(O[Si](C)(C)C)C=C1)N(CCC1=CC=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=C1)[Si](C)(C)C | 3015.4 | Semi standard non polar | 33892256 | | Dobutamine,4TMS,isomer #1 | CC(CCC1=CC=C(O[Si](C)(C)C)C=C1)N(CCC1=CC=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=C1)[Si](C)(C)C | 2715.1 | Standard non polar | 33892256 | | Dobutamine,4TMS,isomer #1 | CC(CCC1=CC=C(O[Si](C)(C)C)C=C1)N(CCC1=CC=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=C1)[Si](C)(C)C | 2866.6 | Standard polar | 33892256 | | Dobutamine,1TBDMS,isomer #1 | CC(CCC1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1)NCCC1=CC=C(O)C(O)=C1 | 3165.5 | Semi standard non polar | 33892256 | | Dobutamine,1TBDMS,isomer #2 | CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O[Si](C)(C)C(C)(C)C)=C1 | 3144.0 | Semi standard non polar | 33892256 | | Dobutamine,1TBDMS,isomer #3 | CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O[Si](C)(C)C(C)(C)C)C(O)=C1 | 3168.7 | Semi standard non polar | 33892256 | | Dobutamine,1TBDMS,isomer #4 | CC(CCC1=CC=C(O)C=C1)N(CCC1=CC=C(O)C(O)=C1)[Si](C)(C)C(C)(C)C | 3290.2 | Semi standard non polar | 33892256 | | Dobutamine,2TBDMS,isomer #1 | CC(CCC1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1)NCCC1=CC=C(O[Si](C)(C)C(C)(C)C)C(O)=C1 | 3340.2 | Semi standard non polar | 33892256 | | Dobutamine,2TBDMS,isomer #2 | CC(CCC1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1)NCCC1=CC=C(O)C(O[Si](C)(C)C(C)(C)C)=C1 | 3325.0 | Semi standard non polar | 33892256 | | Dobutamine,2TBDMS,isomer #3 | CC(CCC1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1)N(CCC1=CC=C(O)C(O)=C1)[Si](C)(C)C(C)(C)C | 3476.5 | Semi standard non polar | 33892256 | | Dobutamine,2TBDMS,isomer #4 | CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)=C1 | 3376.8 | Semi standard non polar | 33892256 | | Dobutamine,2TBDMS,isomer #5 | CC(CCC1=CC=C(O)C=C1)N(CCC1=CC=C(O)C(O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 3466.9 | Semi standard non polar | 33892256 | | Dobutamine,2TBDMS,isomer #6 | CC(CCC1=CC=C(O)C=C1)N(CCC1=CC=C(O[Si](C)(C)C(C)(C)C)C(O)=C1)[Si](C)(C)C(C)(C)C | 3493.5 | Semi standard non polar | 33892256 | | Dobutamine,3TBDMS,isomer #1 | CC(CCC1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1)NCCC1=CC=C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)=C1 | 3563.0 | Semi standard non polar | 33892256 | | Dobutamine,3TBDMS,isomer #2 | CC(CCC1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1)N(CCC1=CC=C(O[Si](C)(C)C(C)(C)C)C(O)=C1)[Si](C)(C)C(C)(C)C | 3708.0 | Semi standard non polar | 33892256 | | Dobutamine,3TBDMS,isomer #3 | CC(CCC1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1)N(CCC1=CC=C(O)C(O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 3680.9 | Semi standard non polar | 33892256 | | Dobutamine,3TBDMS,isomer #4 | CC(CCC1=CC=C(O)C=C1)N(CCC1=CC=C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 3690.9 | Semi standard non polar | 33892256 | | Dobutamine,4TBDMS,isomer #1 | CC(CCC1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1)N(CCC1=CC=C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 3931.0 | Semi standard non polar | 33892256 | | Dobutamine,4TBDMS,isomer #1 | CC(CCC1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1)N(CCC1=CC=C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 3435.2 | Standard non polar | 33892256 | | Dobutamine,4TBDMS,isomer #1 | CC(CCC1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1)N(CCC1=CC=C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 3200.5 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Dobutamine GC-MS (Non-derivatized) - 70eV, Positive | splash10-057r-3900000000-f2923e02084170324b85 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dobutamine GC-MS (3 TMS) - 70eV, Positive | splash10-0uk9-2454290000-9465513295fd096051a4 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dobutamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dobutamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dobutamine GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dobutamine GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dobutamine GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dobutamine GC-MS (TMS_1_4) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dobutamine GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dobutamine GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dobutamine GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dobutamine GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dobutamine GC-MS (TMS_2_5) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dobutamine GC-MS (TMS_2_6) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dobutamine GC-MS (TMS_3_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dobutamine GC-MS (TMS_3_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dobutamine GC-MS (TMS_3_4) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dobutamine GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dobutamine GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dobutamine GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dobutamine GC-MS (TBDMS_1_4) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dobutamine GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dobutamine GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dobutamine GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dobutamine GC-MS (TBDMS_2_4) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Dobutamine LC-ESI-QQ , positive-QTOF | splash10-0udi-0009000000-72fe7c46458e5a5d842b | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Dobutamine LC-ESI-QQ , positive-QTOF | splash10-0udi-0409000000-f41b2ba5a7a16faab22e | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Dobutamine LC-ESI-QQ , positive-QTOF | splash10-052r-0900000000-5a6988f6f954cc4d5970 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Dobutamine LC-ESI-QQ , positive-QTOF | splash10-0a4r-1900000000-3760790cd7d468deb65b | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Dobutamine LC-ESI-QQ , positive-QTOF | splash10-0a4l-4900000000-8656459c9b16b99f096c | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Dobutamine LC-ESI-IT , positive-QTOF | splash10-05n0-0900000000-b4956c2ea5a7aa86eb32 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Dobutamine LC-ESI-QTOF , positive-QTOF | splash10-0udi-0009000000-99dd6da8a1a7db9cdda3 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Dobutamine LC-ESI-QTOF , positive-QTOF | splash10-0f79-0903000000-297b7061da4a9bff6e29 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Dobutamine LC-ESI-QTOF , positive-QTOF | splash10-0a4r-1900000000-a5825e1ad3ae4837917c | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Dobutamine LC-ESI-QTOF , positive-QTOF | splash10-0a4l-3900000000-84358b5b309fe282e24e | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Dobutamine LC-ESI-QTOF , positive-QTOF | splash10-0a4l-8900000000-fbdc06bd7571ae3e38a5 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Dobutamine 20V, Positive-QTOF | splash10-0f79-0903000000-3890980670c4ffca8018 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Dobutamine 40V, Positive-QTOF | splash10-0a4l-3900000000-e490ed53134da979dc5b | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Dobutamine 50V, Positive-QTOF | splash10-0a4l-8900000000-fbdc06bd7571ae3e38a5 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Dobutamine 30V, Positive-QTOF | splash10-0a4r-1900000000-40e3634057b84ae27896 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Dobutamine 40V, Positive-QTOF | splash10-0a4l-3900000000-84358b5b309fe282e24e | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Dobutamine 30V, Positive-QTOF | splash10-0a4r-1900000000-a5825e1ad3ae4837917c | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Dobutamine 10V, Positive-QTOF | splash10-0udi-0009000000-99dd6da8a1a7db9cdda3 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Dobutamine 20V, Positive-QTOF | splash10-0f79-0903000000-297b7061da4a9bff6e29 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dobutamine 10V, Positive-QTOF | splash10-0udi-0419000000-f94f8045c53cdac06b38 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dobutamine 20V, Positive-QTOF | splash10-0k9j-0911000000-c07cfe14c28ee716fddb | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dobutamine 40V, Positive-QTOF | splash10-0a70-5900000000-ba6987861a46cdc959a3 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dobutamine 10V, Negative-QTOF | splash10-0udi-0109000000-83f213f0b5786d86e0de | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dobutamine 20V, Negative-QTOF | splash10-0udi-0429000000-a764f2b18bf3f07d9ed3 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dobutamine 40V, Negative-QTOF | splash10-0uk9-1910000000-a0ed2c4b984d7efe415f | 2016-08-03 | Wishart Lab | View Spectrum |
|
|---|